Suchergebnisse - "cytokine release syndrome"

PubPharm (1.396)

1341

Transplanters drive CARs to the clinic by brewing ICE-T: the Moffitt roadmap

in: Journal for ImmunoTherapy of Cancer | 2017

von Frederick L. Locke | Claudio Anasetti | for the Moffitt Immunotherapy Working Group and the Immune Cell Therapy (ICE-T) Program

1342

At The Bedside : Clinical review of chimeric antigen receptor (CAR) T cell therapy for B cell malignancies

enthalten in: Journal of leukocyte biology | 2016

von Oluwole, O. | Davila, M.

1343

Blinatumomab provoked fatal heart failure

enthalten in: International immunopharmacology | 2016

von Darvishi, B. | Farahmand, L. | Jalili, N. | +1

1344

Review : Current clinical applications of chimeric antigen receptor (CAR) modified T cells

enthalten in: Cytotherapy | 2016

von Geyer, M. | Brentjens, R.

1345

Severe Cytokine-Release Syndrome after T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti-IL-6 Therapy Is Safe and Well Tolerated

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2016

von Abboud, R. | Keller, J. | Slade, M. | +11

CommentIn: Biol Blood Marrow Transplant. 2016 Oct;22(10 ):1736-1737. - PMID 27543158

1346

Cytokine release : A workshop proceedings on the state-of-the-science, current challenges and future directions

enthalten in: Cytokine | 2016

von Grimaldi, C. | Finco, D. | Fort, M. | +12

1347

Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy

enthalten in: Journal of hematology & oncology | 2016

von Hu, Y. | Sun, J. | Wu, Z. | +9

1348

Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy

enthalten in: Journal of hematology & oncology | 2016

von Hu, Y. | Sun, J. | Wu, Z. | +9

1349

Blinatumomab : Bridging the Gap in Adult Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

enthalten in: Clinical lymphoma, myeloma & leukemia | 2016

von Folan, S. | Rexwinkle, A. | Autry, J. | +1

1350

Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia

enthalten in: Annals of hematology | 2016

von Kim, T. | Xu, M. | Podoltsev, N. | +8